Biopharmaceutical Considerations Part 1 Flashcards

1
Q

What are the factors that affect GIT site absorption?

A
  1. Drug substance (API) properties (pH, solubility, ionisation.
  2. How drug product is formulated (dosage form)
  3. Site of administration (better absorption with many blood vessels present)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What steps must occur for absorption to take place?

A
  1. drug must be released from the formulation/product (except oral solutions)
  2. enter into the gut lumen’s fluids/juices
  3. dissolved free drug diffuse to the gut wall epithelia/lining.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is dissolution vs drug release?

A

Dissolution: processes (e.g disintegration or capsule rupture) that cause solvation of drug substance from orally administered IR Immediate-Release solid dosage forms

Drug release: drug release of non-oral dosage forms (i.e. topical, transdermal, suppositories, liposomal delivery, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the Processes Affecting Extent of Absorption During GI Transit?

A
  1. Drug substance degradation
  2. Precipitation
  3. Motility
  4. Gut wall/intestinal metabolism
  5. First-pass metabolism
    6.Drug disposition (distribution and elimination)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Elimination includes the processes Excretion and metabolism. T/F

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain how drug products are designed for locally acting drugs.

A
  1. designed to deliver the drug directly to the site of action before reaching the systemic
  2. designed to penetrate no further than the local tissue
  3. administered orally (local GI effect) or applied topically
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rate of drug release and absorption is generally quantified by (Tmax) and (Cmax).
T/F

The extent of drug release and absorption is represented by (AUC)

T/F

A

True
True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the biopharmaceutic factors that affect Drug Product design?

These are also Factors affecting BA (or Drug-System properties

A
  1. Drug substance properties
  2. Formulation of the drug product
  3. Biological characteristics of the patient
  4. Excipients:
    (are inert concerning pharmacodynamic activity
    important in manufacture and functionality of drug product)
  5. Drug disposition influenced by specific formulation of the drug

(For example, encapsulated drug in liposomes/microspheres may change the drug distribution and systemic clearance
addition of mannitol may change the renal clearance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the Considerations in the Design of a Drug Product?

A
  1. Physiochemical properties of the drug substance
  2. Route of drug administration
  3. Desired PD effect
  4. Toxicologic properties of the drug substance and excipients
  5. Effect of excipients and dosage form
  6. Manufacturing processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Considerations for route of administration.

A
  1. Anatomy and physiology of the administration site
  2. Ingredients to be used
  3. pH and tonicity if its for the eye.
  4. Special devices for administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Biopharmaceutic Considerations determine the dose and dosage form of a product.
T/F

A

True
and remember
Strengths of a dosage form usually expressed in unit
Dose adjusted based on weight or surface area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the Rate Limiting Steps in Drug Absorption?

A
  1. Delivery of drug product formulation
  2. Release of the drug substance from the formulation
  3. Transportation to absorption site (cellular permeation)
    4.For non-locally acting drugs, post absorption, there are many rate dependent steps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the rate limiting steps for ER and IR formulations?

A

ER: release of the drug from the formulation
IR: disintegration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is disintegration?

A

process by which dosage forms progressively transforms to smaller drug particles.

eg of dosage form Chewable tablets, troches, liquid filled soft gelatin capsules, SR drug products (osmotic pump, etc. oral dosage forms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of disintegrants.

A

Na starch glycolate
crospovidone,
microcrystalline cellulose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the mechanisms of disintegration?

A

wicking: the disintegrant pulls water into pores
reduce physical bonding force between particles.

swelling: particles swell creating localized stress that spreads and breaks up matrix from within

17
Q

What two factors can result in poor disintegration?

A
  1. High compression
  2. insufficient disintegrant
18
Q

When should you use disintegration instead of or in lieu of dissolution.

A

1.The product rapidly dissolves. (too fast to measure dissolution)
2.The drug is highly soluble throughout the physiological range. (it dissolves immediately)
3.A relationship to dissolution has been established or when disintegration is shown to be more discriminating than dissolution.
(disintegration can give more info).
4.In vitro dissolution tests cannot be done practicaly for highly soluble compounds.

19
Q

What is dissolution?
What is solubility?

A

The process by which a solid drug substance becomes dissolved in a solvent over time (dynamic)

Solubility is the mass of solute that dissolves in a specific mass or volume of solvent at a given temperature (equilibrium)

20
Q

If a drug has poor aqueous solubility (does not dissolve well in water-based fluids like stomach or intestinal fluids), its dissolution rate becomes the rate-limiting step in drug absorption.
T/F

In-vivo dissolution can be rate limiting step.
T/F

21
Q

What is IVIVC?

A

in-vitro-in-vivo correlation)
If there is a strong correlation between in-vitro (lab) and in-vivo (body) dissolution, scientists can use in-vitro tests to predict how the drug will behave in the body.

ie. where experimental dissolution data helps quantitatively predict bioavailability (BA) without needing excessive human/animal trials

22
Q

Noyes and Whitney Equation

A

studied how substances e.g benzoic acid and lead chloride dissolve in water.

Propose that first a saturated solution film forms and that allows for diffusion to take place.

Rate of dissolution is proportional to the difference between the saturation solubility and the instantaneous bulk (well-stirred) concentration

23
Q

According to The Noyes-Whitney equation dissolution is influenced by:

A

1.Physiochemical characteristics of the drug
2.The solvent the drug is dissolving in
3.Level of agitation in the bulk fluid medium
4.Temperature of the fluid medium (solvent

24
Q

What are the Factors Affecting Drug Dissolution in Solid Oral Dosage Form?

A
  1. The physical and chemical nature of the active drug substance
  2. The nature of the excipients
  3. The method of manufacture
  4. The dissolution test conditions
25
Q

How is particle size related to drug absorption?

A

Smaller particles have a greater surface area.
This results in fast rate of dissolution.
And rapid drug absorption